Table 3. Effect of LEV administration on sperm morphology.
Experimental Groups | Abnormal Sperm (%) | Head Abnormality (%) | Tail Abnormality (%) | Multiple Abnormality (%) |
---|---|---|---|---|
C | 24.85 ± 4.88 | 8.75 ± 3.22 | 12.4 ± 3.74 | 3.7 ± 1.58 |
LEV-50 | 38.7 ± 2.98 | 13.55 ± 3.24 | 18.3 ± 2.09 | 6.5 ± 2.04 |
LEV-150 | 46.3 ± 7.02 (a) | 13.3 ± 3.14 | 25.85 ± 3.34 (a) | 7.15 ± 2.75 (a) |
LEV-300 | 59.25 ± 7.21 (aaa,b) | 15.05 ± 3.59 (a) | 35.5 ± 4.47 (aaa,b) | 8.7 ± 3.72 (a) |
C: Control group; LEV-50: 50 mg/kg levetiracetam administered group; LEV-150: 150 mg/kg levetiracetam administered group; LEV-300: 300 mg/kg levetiracetam administered group; Results are Mean ± SD, n = 10.
(a) Different from control group (P < 0.05),
(aaa) Different from control group (P < 0.001),
(b) Different from LEV-50 (P < 0.05).